BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31097287)

  • 1. Risk of malignancy in the categories of the Papanicolaou Society of Cytopathology system for reporting pancreaticobiliary cytology.
    Hoda RS; Finer EB; Arpin RN; Rosenbaum M; Pitman MB
    J Am Soc Cytopathol; 2019; 8(3):120-127. PubMed ID: 31097287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of malignancy associated with diagnostic categories of the proposed World Health Organization International System for Reporting Pancreaticobiliary Cytopathology.
    Hoda RS; Arpin RN; Rosenbaum MW; Pitman MB
    Cancer Cytopathol; 2022 Mar; 130(3):195-201. PubMed ID: 34623767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on risk stratification in the Papanicolaou Society of Cytopathology System for Reporting Pancreaticobiliary Cytology categories: 3-Year, prospective, single-institution experience.
    Sung S; Del Portillo A; Gonda TA; Kluger MD; Tiscornia-Wasserman PG
    Cancer Cytopathol; 2020 Jan; 128(1):29-35. PubMed ID: 31722125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytologic categorization of pancreatic neoplastic mucinous cysts with an assessment of the risk of malignancy: A retrospective study based on the Papanicolaou Society of Cytopathology guidelines.
    Smith AL; Abdul-Karim FW; Goyal A
    Cancer Cytopathol; 2016 Apr; 124(4):285-93. PubMed ID: 26618476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of endoscopic ultrasound-guided pancreatic FNAC diagnosis for solid and cystic lesions at Manchester Royal Infirmary based upon the Papanicolaou Society of Cytopathology pancreaticobiliary terminology classification scheme.
    Wright PK; Shelton DA; Holbrook MR; Thiryayi SA; Narine N; Slater D; Rana DN
    Cytopathology; 2018 Feb; 29(1):71-79. PubMed ID: 29193477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Malignancy Using the Diagnostic Categories Proposed by the World Health Organization International System for Reporting Pancreaticobiliary Cytopathology.
    Gocun PU; Simsek B; Ekinci O; Ekmen N; Arhan M; Karakan T; Ibis M; Cindoruk M
    Acta Cytol; 2022; 66(6):475-485. PubMed ID: 35732161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of the new proposed Papanicolaou Society of Cytopathology terminology for pancreaticobiliary cytology in endoscopic US-FNA: A single-institutional experience.
    Saieg MA; Munson V; Colletti S; Nassar A
    Cancer Cytopathol; 2015 Aug; 123(8):488-94. PubMed ID: 25994860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignancy risk associated with diagnostic categories defined by the Papanicolaou Society of Cytopathology pancreaticobiliary guidelines.
    Layfield LJ; Dodd L; Factor R; Schmidt RL
    Cancer Cytopathol; 2014 Jun; 122(6):420-7. PubMed ID: 24339321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of malignancy associated with the diagnostic categories proposed by the Papanicolaou Society of Cytopathology for pancreaticobiliary specimens: An institutional experience.
    Gonzalez-Mancera MS; Ahmadian SS; Gomez-Fernandez C; Velez-Torres J; Jorda M; García-Buitrago MT
    Diagn Cytopathol; 2022 Feb; 50(2):49-56. PubMed ID: 34856075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytologic Categorization with Risk Stratification of Endoscopic Ultrasound-Guided Fine Needle Aspiration from Pancreatic Lesions Based on Guidelines of the Papanicolaou Society of Cytopathology: 12-Year Tertiary Care Experience.
    Nishith N; Rao RN; Rai P
    Discoveries (Craiova); 2021; 9(3):e134. PubMed ID: 34816002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Performance of Pancreatic Cytology with the Papanicolaou Society of Cytopathology System: A Systematic Review, before Shifting into the Upcoming WHO International System.
    Nikas IP; Proctor T; Seide S; Chatziioannou SS; Reynolds JP; Ntourakis D
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The WHO system versus the Papanicolaou society of cytopathology system for reporting pancreaticobiliary cytology for risk stratification-which is better?
    Kundu R; Kollabathula A; Gupta N; Rohilla M; Rana SS; Nada R; Kalra N; Basher RK; Gupta P; Dey P; Gupta R; Dutta U; Srinivasan R
    Diagn Cytopathol; 2024 Mar; 52(3):145-155. PubMed ID: 38059418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The applicability of Papanicolaou Society of Cytopathology system on reporting endoscopic ultrasound-guided fine needle aspiration cytology specimens of pancreatic lesions in situations with limited availability of ancillary tests. Experience at a single laboratory.
    Mallik MK; Qadan LR; Al Naseer A; AlAli A; Al Ansari T; Naquib SAI; Das DK; Kapila K
    Cytopathology; 2020 Nov; 31(6):564-571. PubMed ID: 32535975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The World Health Organization classification of pancreaticobiliary cytopathology stratifies risk of malignancy and outcome for endoscopic ultrasound-guided fine-needle aspiration of the pancreas.
    Lui SK; Hargett I; Pharaa Z; Aviles M; Botelho S; Feliciano DL; Kim V; Sigel K; Armstrong M; Wilson CE; Shah P; Soares K; Sigel C
    Cancer Cytopathol; 2023 Dec; 131(12):762-771. PubMed ID: 37602886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic sensitivity and risk of malignancy for bile duct brushings categorized by the Papanicolaou Society of Cytopathology System for reporting pancreaticobiliary cytopathology.
    Layfield LJ; Zhang T; Esebua M
    Diagn Cytopathol; 2022 Jan; 50(1):24-27. PubMed ID: 34800330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Contribution of Standardized Terminology for Pancreatic Lesions' Cytopathology.
    Bakkaloglu OK; Kepil N; Yildirim S; Atay K; Tuncer M; Dobrucalı AM; Erzin Y
    Acta Cytol; 2022; 66(6):486-495. PubMed ID: 36067732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A modified Papanicolaou Society of Cytopathology system for reporting respiratory cytology specimens: Implications for estimates of malignancy risk and diagnostic accuracy.
    Layfield LJ; Esebua M
    Diagn Cytopathol; 2021 Nov; 49(11):1167-1172. PubMed ID: 34319004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic ultrasound-guided pancreatic fine-needle aspiration: potential pitfalls in one institution's experience of 1212 procedures.
    Bergeron JP; Perry KD; Houser PM; Yang J
    Cancer Cytopathol; 2015 Feb; 123(2):98-107. PubMed ID: 25410732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Papanicolaou Society of Cytopathology new guidelines have a greater ability of risk stratification for pancreatic endoscopic ultrasound-guided fine-needle aspiration specimens.
    Chen B; Zhao Y; Gu J; Wu H; Liang Z; Meng Z
    Oncotarget; 2017 Jan; 8(5):8154-8161. PubMed ID: 28042957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The frequency and cancer risk associated with the atypical cytologic diagnostic category in endoscopic ultrasound-guided fine-needle aspiration specimens of solid pancreatic lesions: a meta-analysis and argument for a Bethesda System for Reporting Cytopathology of the Pancreas.
    Abdelgawwad MS; Alston E; Eltoum IA
    Cancer Cytopathol; 2013 Nov; 121(11):620-8. PubMed ID: 23881871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.